WallStreetZenWallStreetZen

NASDAQ: SCYX
Scynexis Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their SCYX stock forecasts and price targets.

Forecast return on equity

Is SCYX forecast to generate an efficient return?

Company
-0.77%
Industry
30.74%
Market
90.47%
SCYX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SCYX forecast to generate an efficient return on assets?

Company
-0.57%
Industry
15.4%
SCYX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SCYX earnings per share forecast

What is SCYX's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.52
Avg 2 year Forecast
$1.50
Avg 3 year Forecast
-$0.07

SCYX revenue forecast

What is SCYX's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$16.8M+539.54%
Avg 2 year Forecast
$114.2M+4,243.35%
Avg 3 year Forecast
$40.3M+1,432.7%
SCYX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SCYX revenue growth forecast

How is SCYX forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
148.4%
Industry
4.14%
Market
9.68%
SCYX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SCYX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SCYX vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
SCYX$0.81N/AN/A
RMTI$0.94$3.00+219.15%Buy
KALA$4.30$13.50+213.95%Buy
APUS$1.83N/AN/A
GELS$2.10N/AN/A
View Top Pharmaceutical Stocks

Scynexis Stock Forecast FAQ

What is SCYX's earnings growth forecast for 2025-2027?

(NASDAQ: SCYX) Scynexis's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 25.78%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Scynexis's earnings in 2025 is -$27,090,000.On average, 1 Wall Street analyst forecast SCYX's earnings for 2025 to be -$20,290,542, with the lowest SCYX earnings forecast at -$20,290,542, and the highest SCYX earnings forecast at -$20,290,542. On average, 1 Wall Street analyst forecast SCYX's earnings for 2026 to be $58,530,411, with the lowest SCYX earnings forecast at $58,530,411, and the highest SCYX earnings forecast at $58,530,411.

In 2027, SCYX is forecast to generate -$2,731,419 in earnings, with the lowest earnings forecast at -$2,731,419 and the highest earnings forecast at -$2,731,419.

If you're new to stock investing, here's how to buy Scynexis stock.

What is SCYX's revenue growth forecast for 2025-2027?

(NASDAQ: SCYX) Scynexis's forecast annual revenue growth rate of 148.4% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.14%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Scynexis's revenue in 2025 is $2,630,000.On average, 1 Wall Street analysts forecast SCYX's revenue for 2025 to be $656,321,009, with the lowest SCYX revenue forecast at $656,321,009, and the highest SCYX revenue forecast at $656,321,009. On average, 1 Wall Street analysts forecast SCYX's revenue for 2026 to be $4,457,285,899, with the lowest SCYX revenue forecast at $4,457,285,899, and the highest SCYX revenue forecast at $4,457,285,899.

In 2027, SCYX is forecast to generate $1,572,907,245 in revenue, with the lowest revenue forecast at $1,572,907,245 and the highest revenue forecast at $1,572,907,245.

What is SCYX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SCYX) forecast ROA is -0.57%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 15.4%.

What is SCYX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SCYX) Scynexis's current Earnings Per Share (EPS) is -$0.56. On average, analysts forecast that SCYX's EPS will be -$0.52 for 2025, with the lowest EPS forecast at -$0.52, and the highest EPS forecast at -$0.52. On average, analysts forecast that SCYX's EPS will be $1.50 for 2026, with the lowest EPS forecast at $1.50, and the highest EPS forecast at $1.50. In 2027, SCYX's EPS is forecast to hit -$0.07 (min: -$0.07, max: -$0.07).

What is SCYX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SCYX) forecast ROE is -0.77%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.